The Neglected Role of Bile Duct Epithelial Cells in NASH.


Journal

Seminars in liver disease
ISSN: 1098-8971
Titre abrégé: Semin Liver Dis
Pays: United States
ID NLM: 8110297

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 19 11 2021
medline: 6 5 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and affects 25% of the population in Western countries. NAFLD is the hepatic manifestation of the metabolic syndrome, linked to insulin resistance, which is the common pathogenetic mechanism. In approximately 40% of NAFLD patients, steatosis is associated with necro-inflammation and fibrosis, resulting in nonalcoholic steatohepatitis (NASH), a severe condition that may progress to cirrhosis and liver cancer. Although the hepatocyte represents the main target of the disease, involvement of the bile ducts occurs in a subset of patients with NASH, and is characterized by ductular reaction and activation of the progenitor cell compartment, which incites portal fibrosis and disease progression. We aim to dissect the multiple biological effects that adipokines and metabolic alterations exert on cholangiocytes to derive novel information on the mechanisms driven by insulin resistance, which promote fibro-inflammation and carcinogenesis in NASH.

Identifiants

pubmed: 34794182
doi: 10.1055/s-0041-1739455
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-47

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Massimiliano Cadamuro (M)

Department of Molecular Medicine (DMM), University of Padua, Padua, Italy.

Alberto Lasagni (A)

Division of General Medicine, Padua University-Hospital, Padua, Italy.

Samantha Sarcognato (S)

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.

Maria Guido (M)

Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.
Department of Medicine (DIMED), University of Padua, Padua, Italy.

Roberto Fabris (R)

Division of Clinica Medica 3, Center for the Study and the Integrated Management of Obesity, Padua University-Hospital, Padua, Italy.

Mario Strazzabosco (M)

Department of Internal Medicine, Digestive Disease Section, Liver Center, Yale University, New Haven, Connecticut.

Alastair J Strain (AJ)

School of Biosciences, University of Birmingham, Birmingham, United Kingdom.

Paolo Simioni (P)

Division of General Medicine, Padua University-Hospital, Padua, Italy.
Department of Medicine (DIMED), University of Padua, Padua, Italy.

Erica Villa (E)

Gastroenterology Unit, Department of Medical Specialties, University of Modena & Reggio Emilia and Modena University-Hospital, Modena, Italy.

Luca Fabris (L)

Department of Molecular Medicine (DMM), University of Padua, Padua, Italy.
Division of General Medicine, Padua University-Hospital, Padua, Italy.
Department of Internal Medicine, Digestive Disease Section, Liver Center, Yale University, New Haven, Connecticut.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH